TY  - JOUR
AU  - Saito, Motonobu
AU  - Kono, Koji
AU  - Kohno, Takashi
PY  - 2018
TI  - Identification of a novel therapeutic target in driver-negative nonsmall cell lung cancer
JF  - Translational Lung Cancer Research; Vol 7, Supplement 3 (September 26, 2018): Translational Lung Cancer Research1
Y2  - 2018
KW  - 
N2  - Molecular targeted therapy against driver gene aberrations has a significantly high positive response rate compared with traditional cytotoxic chemotherapies, and has thus dramatically changed the treatment strategies for malignant tumors, including non-small cell lung cancer (NSCLC) (1). Lung adenocarcinoma (LADC) can be treated with targeted therapy against driver gene aberrations using tyrosine kinase inhibitors (TKIs).
UR  - https://tlcr.amegroups.org/article/view/23560